Down 19%, Is It Time to Buy the Dip on Nvidia Stock?

Nvidia (market cap $4.07T) shows trailing P/E 35.7 and P/S 19.9 vs. forward P/E 21.1 and forward P/S 11.5, driven by recent revenue growth of +73% YoY and EPS +98% YoY. Reports that Nvidia has resumed H200 production for China and may introduce a China-friendly Groq 3 inference chip imply a potential revenue upside of about $32B/year that was not included in current estimates, which could push forward P/S into single digits and P/E below 20. Given the magnitude of the upside versus current forward multiples, the piece frames Nvidia as a potentially attractive buy, though the upgrade is conditional on unconfirmed China revenue resumption.

Analysis

If China-derived incremental demand materializes in coming quarters, the re-rating mechanics will be driven less by headline multiples and more by operating leverage: incremental revenue for premium AI silicon largely drops to operating profit because R&D and fixed fab capacity are already sunk, so every incremental dollar compounds FCF and expands free-cash-flow yield materially. That implies a convex stock response to upside surprises — modest beat -> outsized multiple expansion — but also creates vulnerability to disappointment if shipments slip or are delayed by logistics or regulatory holds.

Second-order winners include foundries and capital-equipment vendors that enable rapid capacity turn-up; expect revenue and margin tailwinds at those suppliers if designs scale into new fabs quickly. Conversely, vendors offering lower-margin, local alternatives or inference-only chips could constrain pricing power over time, pressuring ASPs in lower tiers and compressing incremental margins if Nvidia is forced to offer China-specific SKUs with differentiated price/performance.

Key catalysts to watch are shipment and install cadence at hyperscalers (near-term, 1–2 quarters) and any public signals on export-control compliance or regulatory clearances (1–6 months). Tail risks are binary and asymmetric: sudden policy tightening or a high-profile customer inventory flush could erase the convex upside and trigger >30% downside; alternatively, sustained adoption of new architectures could lift shares 20–50% within 6–12 months.

Given elevated optionality and asymmetric policy risk, preferred execution is calibrated exposure with defined downside protection and pair-hedges to neutralize macro/tech-cyclical swings. Trade implementation should be timed around earnings and visible shipment updates to capture volatility compression on positive confirmation.

Key Decisions for Investors

• Long NVDA equity (size 2–4% portfolio): build into any 10–20% pullback ahead of the next two quarterly reports; target 20–35% upside over 6–12 months if incremental China-related revenue is confirmed. Use a hard stop at 18% absolute loss or implement a protective 6–9 month put (cost ~1–3% of notional) to cap downside.
• Buy 9–15 month call spread (NVDA LEAP debit spread): buy longer-dated OTM call, sell a higher OTM call to fund premium. Objective: 2–4x return if thesis realizes within 9–15 months with max loss limited to premium; run to earnings + two supply-cycle quarters.
• Pair trade — long NVDA / short INTC (equal-dollar, size 1–2% net long NVDA): horizon 3–9 months to capture structural outperformance while hedging broader semiconductor cycle risk. Reward: asymmetric if NVDA re-rates; risk: INTC technical breakthrough or product beat reducing spread — cap position size and re-assess after each earnings print.
• Volatility-protected collar for core exposure: buy NVDA and fund 6–12 month 10–15% OTM puts by selling 25–35% OTM calls. This reduces cost basis, limits downside to protected band, and monetizes high IV on the call side while allowing for meaningful upside participation over 6–12 months.